WO2013070988A3 - Procédé de traitement de l'ostéosarcome - Google Patents

Procédé de traitement de l'ostéosarcome Download PDF

Info

Publication number
WO2013070988A3
WO2013070988A3 PCT/US2012/064255 US2012064255W WO2013070988A3 WO 2013070988 A3 WO2013070988 A3 WO 2013070988A3 US 2012064255 W US2012064255 W US 2012064255W WO 2013070988 A3 WO2013070988 A3 WO 2013070988A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating osteosarcoma
osteosarcoma
treating
compositions
disclosed
Prior art date
Application number
PCT/US2012/064255
Other languages
English (en)
Other versions
WO2013070988A2 (fr
Inventor
Hooshmand Sheshbaradaran
Original Assignee
Niiki Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niiki Pharma Inc. filed Critical Niiki Pharma Inc.
Publication of WO2013070988A2 publication Critical patent/WO2013070988A2/fr
Publication of WO2013070988A3 publication Critical patent/WO2013070988A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés et des compositions pour traiter l'ostéosarcome.
PCT/US2012/064255 2011-11-09 2012-11-09 Procédé de traitement de l'ostéosarcome WO2013070988A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161557427P 2011-11-09 2011-11-09
US61/557,427 2011-11-09

Publications (2)

Publication Number Publication Date
WO2013070988A2 WO2013070988A2 (fr) 2013-05-16
WO2013070988A3 true WO2013070988A3 (fr) 2013-07-25

Family

ID=48290765

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/064255 WO2013070988A2 (fr) 2011-11-09 2012-11-09 Procédé de traitement de l'ostéosarcome

Country Status (1)

Country Link
WO (1) WO2013070988A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032801A1 (en) * 2001-01-26 2005-02-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Compositions containing a ruthenium(III) complex and a heterocycle
US20090318402A1 (en) * 2006-03-07 2009-12-24 The University Court Of The University Of Edinburg Ruthenium (ii) compounds
US20100094019A1 (en) * 2007-06-11 2010-04-15 Keppler Berhhard Method of manufacturing a ruthenium complex
WO2010121245A1 (fr) * 2009-04-17 2010-10-21 Niiki Pharma Inc. Méthode de traitement du carcinome hépatocellulaire

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032801A1 (en) * 2001-01-26 2005-02-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Compositions containing a ruthenium(III) complex and a heterocycle
US20090318402A1 (en) * 2006-03-07 2009-12-24 The University Court Of The University Of Edinburg Ruthenium (ii) compounds
US20100094019A1 (en) * 2007-06-11 2010-04-15 Keppler Berhhard Method of manufacturing a ruthenium complex
WO2010121245A1 (fr) * 2009-04-17 2010-10-21 Niiki Pharma Inc. Méthode de traitement du carcinome hépatocellulaire

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HEFFETER, P. ET AL.: "Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339", JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, vol. 15, June 2010 (2010-06-01), pages 737 - 748, XP019854157 *
HUDEJ, R. ET AL.: "The Influence of Electroporation on Cytotoxicity of Anticancer Ruthenium(III) Complex KP1339 In Vitro and In Vivo", ANTICANCER RESEARCH, vol. 30, June 2010 (2010-06-01), pages 2055 - 2063 *

Also Published As

Publication number Publication date
WO2013070988A2 (fr) 2013-05-16

Similar Documents

Publication Publication Date Title
WO2012149472A9 (fr) Procédés, compositions et trousses pour traiter et prévenir des états neurologiques
ZA201400005B (en) Method for treating eczema
EP2523944A4 (fr) Composés et compositions pour l'amélioration de la cognition, leurs procédés de fabrication, et méthodes de traitement
EP2714081A4 (fr) Méthodes, compositions et trousses pour le traitement du cancer
GB2494845B (en) Compositions and methods for treating automotive surfaces
EP2684167A4 (fr) Compositions et méthodes utiles dans le traitement de maladies
EP2701742A4 (fr) Compositions et méthode de traitement de maladies auto-immunes
ZA201208219B (en) Method for treating wasterwater
EP2766009A4 (fr) Procédé et compositions de traitement de la peau
WO2011085351A9 (fr) Procédé de traitement de troubles liés à kcnq
EP2725901A4 (fr) Compositions, méthodes et nécessaires pour traiter la leucémie
WO2013023151A3 (fr) Compositions et méthodes de traitement de maladie cœliaque
PL2681280T3 (pl) Biomateriał, sposób wytwarzania biomateriału i jego zastosowanie
GB201013975D0 (en) Method of treating desease
WO2013038269A3 (fr) Appareil et procédés permettant de traiter des morceaux de tiges de canne à sucre
WO2012061086A3 (fr) Procédé de traitement de tumeurs neuroendocrines
RS57395B1 (sr) Postupak za tretman čelika
EP2723346A4 (fr) Compositions et procédés utiles pour traiter la pédiculose
ZA201301238B (en) An emulsifier,and method of deriving parameters for an emulsifier
WO2013003465A9 (fr) Procédés et compositions pour traiter la peau
WO2013009678A3 (fr) Compositions et méthodes de traitement d'infection par un norovirus
WO2013070988A3 (fr) Procédé de traitement de l'ostéosarcome
WO2013013238A3 (fr) Composés, compositions apparentées et procédés d'utilisation
WO2011133480A3 (fr) Procédé de traitement du cancer gastrique
EP2560659A4 (fr) Compositions et méthode utilisées pour le traitement du myélome multiple

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 12847639

Country of ref document: EP

Kind code of ref document: A2